Publications & Presentations
Gaurav Munj2026-05-10T14:32:36+00:00
Publication of Full Data | The Lancet | May 2025 (Published)
Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa Wounds (VIITAL™): A Two-Centre, Randomised, Open-Label, Intrapatient-Controlled Phase 3 Trial
Press Release Summary
Publication of Full Data | Orphanet Journal of Rare Diseases | October 17, 2022
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa
Publication
